Movement Alert｜Sinopharm Group Declines 3.38% in Regular Trading, Multiple Institutional Investors Reduce Holdings Weighing on Sentiment

Market Focus07-09 15:14

On July 9, Sinopharm Group (01099.HK) fell 3.38% in regular trading, trading at HK$16.6/share, with turnover of HK$84.11 million. The decline comes amid a wave of institutional selling pressure.

On the news front, JPMorgan disclosed a reduction of approximately 874,000 shares on June 30 at HK$16.0054 per share, bringing its stake to 5.97%. Earlier, BlackRock reduced its long position from 10.19% to 9.63% on June 22, while FMR LLC sold 2 million shares at HK$16.82 on June 16. Southbound funds have also been net sellers, with cumulative net reductions of approximately 14.64 million shares over the past 20 trading days. While China CITIC Financial Asset Management increased its position on June 26, overall institutional selling pressure has weighed on market confidence.

Within the Health Care Distributors sector, the broader group traded lower. Among individual stocks, 160 Health down 3.38%, Baiyunshan Pharma down 1.23%, Shanghai Pharma down 1.69%, YSB down 5.42%, and Guanze Medical down 9.26%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1188166087?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-09 15:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1188166087","market":"us","top_or_hot":-1,"title":"Movement Alert｜Sinopharm Group Declines 3.38% in Regular Trading, Multiple Institutional Investors Reduce Holdings Weighing on Sentiment","media":"Market Focus","content":"<p><p>On July 9, Sinopharm Group (01099.HK) fell 3.38% in regular trading, trading at HK$16.6/share, with turnover of HK$84.11 million. The decline comes amid a wave of institutional selling pressure.</p><p>On the news front, JPMorgan disclosed a reduction of approximately 874,000 shares on June 30 at HK$16.0054 per share, bringing its stake to 5.97%. Earlier, BlackRock reduced its long position from 10.19% to 9.63% on June 22, while FMR LLC sold 2 million shares at HK$16.82 on June 16. Southbound funds have also been net sellers, with cumulative net reductions of approximately 14.64 million shares over the past 20 trading days. While China CITIC Financial Asset Management increased its position on June 26, overall institutional selling pressure has weighed on market confidence.</p><p>Within the Health Care Distributors sector, the broader group traded lower. Among individual stocks, 160 Health down 3.38%, Baiyunshan Pharma down 1.23%, Shanghai Pharma down 1.69%, YSB down 5.42%, and Guanze Medical down 9.26%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Sinopharm Group Declines 3.38% in Regular Trading, Multiple Institutional Investors Reduce Holdings Weighing on Sentiment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Sinopharm Group Declines 3.38% in Regular Trading, Multiple Institutional Investors Reduce Holdings Weighing on Sentiment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-09 15:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 9, Sinopharm Group (01099.HK) fell 3.38% in regular trading, trading at HK$16.6/share, with turnover of HK$84.11 million. The decline comes amid a wave of institutional selling pressure.</p><p>On the news front, JPMorgan disclosed a reduction of approximately 874,000 shares on June 30 at HK$16.0054 per share, bringing its stake to 5.97%. Earlier, BlackRock reduced its long position from 10.19% to 9.63% on June 22, while FMR LLC sold 2 million shares at HK$16.82 on June 16. Southbound funds have also been net sellers, with cumulative net reductions of approximately 14.64 million shares over the past 20 trading days. While China CITIC Financial Asset Management increased its position on June 26, overall institutional selling pressure has weighed on market confidence.</p><p>Within the Health Care Distributors sector, the broader group traded lower. Among individual stocks, 160 Health down 3.38%, Baiyunshan Pharma down 1.23%, Shanghai Pharma down 1.69%, YSB down 5.42%, and Guanze Medical down 9.26%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01099","symbol_name":"国药控股","start_time":0,"source_url":"","article_id":"1188166087","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1188166087","pubTimestamp":1783581286,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 9, Sinopharm Group (01099.HK) fell 3.38% in regular trading, trading at HK$16.6/share, with turnover of HK$84.11 million. The decline comes amid a wave of institutional selling pressure.On...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01099":"国药控股"},"translate_title":"动向提示|国药集团常规交易跌3.38%多家机构投资者减持打压情绪","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01099":1},"content_text":"On July 9, Sinopharm Group (01099.HK) fell 3.38% in regular trading, trading at HK$16.6/share, with turnover of HK$84.11 million. The decline comes amid a wave of institutional selling pressure.On the news front, JPMorgan disclosed a reduction of approximately 874,000 shares on June 30 at HK$16.0054 per share, bringing its stake to 5.97%. Earlier, BlackRock reduced its long position from 10.19% to 9.63% on June 22, while FMR LLC sold 2 million shares at HK$16.82 on June 16. Southbound funds have also been net sellers, with cumulative net reductions of approximately 14.64 million shares over the past 20 trading days. While China CITIC Financial Asset Management increased its position on June 26, overall institutional selling pressure has weighed on market confidence.Within the Health Care Distributors sector, the broader group traded lower. Among individual stocks, 160 Health down 3.38%, Baiyunshan Pharma down 1.23%, Shanghai Pharma down 1.69%, YSB down 5.42%, and Guanze Medical down 9.26%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1188166087","isCrawlerRequest":true}